Discussing benefits and risks with patients

Australian Family Physician

Volumn 33, Issue 4, 2004, Pages 266-267

  Bird, Sara ^a  

^a MDA National   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ARTICLE; AUSTRALIA; BLOOD; CASE REPORT; GENERAL PRACTICE; HUMAN; LEGAL ASPECT; LEGAL LIABILITY; MALE; MASS SCREENING; METHODOLOGY; MIDDLE AGED; PATIENT EDUCATION; PROSTATE TUMOR; RISK ASSESSMENT; UNITED STATES;

AUSTRALIA; FAMILY PRACTICE; HUMANS; LIABILITY, LEGAL; MALE; MASS SCREENING; MIDDLE AGED; PATIENT EDUCATION; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; RISK ASSESSMENT; UNITED STATES;

EID: 3042762936     PISSN: 03008495     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (7)

1. Merenstein D. Winners and Losers. JAMA 2004;291:115-116.
2. Harris M, Frydenberg M, Costello A, et al. The PSA debate. Aust Fam Physician 2003;32:395-399.
3. Donovan JL, Frankel SJ, Neal DE, et al. Screening for prostate cancer in the UK. BMJ 2001;323:763-764.
4. The Royal Australian College of General Practitioners. Guidelines for preventive activities in general practice. 5th edn. Melbourne: RACGP, 2001.,
5. The Cancer Council Australia. Prostate cancer - key points.
6. Paling J. Strategies to help patients understand risks. BMJ 2003;327:745-748.
7. Towle A, Godolphin W. Framework for teaching and learning informed shared decision making. BMJ 1999;319:766-771.